On-Demand | Neuropsychotropic Drug Therapy 2021: Psychopharmacology for Depression During Pregnancy and Postpartum
Psychopharmacology for Depression During Pregnancy and Postpartum
Amritha Bhat, MBBS, MD, MPH
Acting Assistant Professor, Psychiatry, School of Medicine, University of Washington, Seattle
Objectives for Learning Outcomes
At the conclusion of this activity, participants will be better able to:
- Describe risks of untreated depression and anxiety during pregnancy and postpartum for mothers and children.
- Discuss recent findings regarding risks of psychotropic medications during pregnancy and postpartum.
- Discuss how recent findings affect informed consent discussions with patients.
- 1.20 Contact hours
- 1.20 Pharmacology hours at the advanced practice level